Biopharma investment trends continue to shift, with venture funding jumping to $7.4 billion across 188 deals for the first ...

Digital business cards. Gilead’s virtual reality ride. Soccer’s Champions League final. A motorcycle brigade. | Digital ...

Charles River Laboratories and Sanofi are working on a new project in which virtual control animals will take the place of ...

It’s all systems go for Moon Surgical with a new FDA green light for its Maestro robotic laparoscopy platform. | It’s all ...

The IPO announcement comes two days after epilepsy biotech Rapport Therapeutics revealed plans for a $122 million IPO, one of ...

Dexcom announced that its G7 diabetes sensor can now link directly to a user’s Apple Watch, allowing them to track their ...

Lykos Therapeutics’ attempt to get the first ever MDMA treatment approved in post-traumatic stress disorder suffered a ...

Vir Biotechnology's hepatitis D combination therapy has shown early efficacy in results from a phase 2 trial, suggesting the ...

Gilead Sciences shared more data on its $4.3 billion, near-approval liver disease prospect Wednesday, linking the candidate ...

Though immunotherapies have made strong inroads in the fight against cancer, knowing which drugs will work the best in which ...

Merck KGaA is hoping to sprout some new oncology and immunology therapeutics with Biolojic Design’s AI-driven drug discovery ...

Illumina’s multibillion-dollar quest for Grail—high-reaching, yet ultimately doomed—is nearing its conclusion. The DNA ...